ReportsAmyotrophic Lateral Sclerosis

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis

See allHide authors and affiliations

Science Translational Medicine  24 May 2017:
Vol. 9, Issue 391, eaaf3962
DOI: 10.1126/scitranslmed.aaf3962

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article